IFNA2 and neoplasm: Interferon treatment significantly reduced primary tumor growth in mice injected with HT168-M1 cells, resulting in a 69% and 86% decrease in the weight of the splenic tumor in mice treated with 105 and 5 × 105 U IFN-α2a, respectively (Figure 2).